mRNA Therapeutics Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What are the Key Projections for the CAGR of the mRNA Therapeutics Market From 2025 to 2034?
The size of the mRNA therapeutics market has been witnessing consistent growth over the past few years. It is projected to rise from $34.76 billion in 2024 to $36.25 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.3%. Factors contributing to historical growth include enhanced funding for the development of effective drugs and vaccines, the establishment of government initiatives aimed at promoting RNA-based medications, increased understanding of uncommon genetic illnesses, and a surge in clinical trials.
In the coming years, a consistent escalation in the mRNA therapeutics market size has been projected. By 2029, it is anticipated to reach $42.23 billion with a compound annual growth rate (CAGR) of 3.9%. Factors contributing to the predicted growth during this forecast period include increasing instances of infectious diseases, higher patient count in hospitals and clinics, widened applications of mRNA therapeutics, rising demand for custom-tailored and precision medicine, positive regulatory conditions, and quickened approval processes. Leading trends for this period encompass developments in mRNA delivery technologies, the swift progression and adaptation of mRNA vaccines, the rise of self-amplifying mRNA (saRNA) platforms, the scalability and adaptability of mRNA production, and the invention of novel mRNA modifications.
What Drivers Are Shaping the Growth of the mRNA Therapeutics Market?
The surge in instances of persistent and infectious diseases is anticipated to fuel the expansion of the mRNA therapeutics market. Diseases that have a long duration and that are spread from person to person, such as tuberculosis, HIV/AIDS, and hepatitis are considered persistent and infectious. The rise of these ailments can be attributed to growing international travels and insufficient health care setups, both of which contribute to their spread and inhibit their control. mRNA therapeutics offer a valuable treatment option for these diseases by quickly elliciting protein production in the body that enhances immune reactions, which results in faster creation of vaccines and treatments. For example, GOV.UK, a governmental website in the UK, reported in October 2023 that in 2022, the number of people in England diagnosed with HIV and receiving treatment was 94,397, a 3% rise from the 91,368 individuals in 2021. Consequently, this escalating occurrence of persistent and infectious diseases acts as a catalyst for the growth of the mRNA therapeutics market.
Request Your Free mRNA Therapeutics Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp
What Are the Key Industry Players Leading the Charge in the mRNA Therapeutics Market’s Growth?
Major companies operating in the mRNA therapeutics market are:
• Pfizer Inc._x000D_
• Novartis AG_x000D_
• Sanofi AG_x000D_
• AstraZeneca plc_x000D_
• GlaxoSmithKline plc_x000D_
How Are Market Trends and Shifts Impacting the Growth Trajectory of the mRNA Therapeutics Market?
Leading companies in the mRNA therapeutics market are focusing on creating innovative solutions like mRNA-based booster vaccines to improve immunity against constantly changing viral strains. An mRNA-based booster vaccine leverages messenger RNA technology to reinforce and extend protection against specific viruses often after the primary vaccine series. For instance, in June 2023, India’s Gennova Biopharmaceuticals Ltd. introduced the country’s first domestic mRNA-based booster vaccine specifically designed for the Omicron variant of SARS-CoV-2, known as GEMCOVAC-OM. This variant-specific vaccine is designed to trigger appropriate immunity against the Omicron variant. GEMCOVAC-OM is thermostable and doesn’t necessitate ultra-cold chain facilities, and it is deliverable without using a needle through a needle-free system, thus simplifying its roll-out in remote parts in India. It was found in clinical trials to significantly boost immune responses compared to other vaccines, underlining the requirement for variant-specific vaccines to produce optimal immunity.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Which Growth-Oriented Segments of the mRNA Therapeutics Market Are Leading the Industry’s Development?
The mRNA therapeutics market covered in this report is segmented –
1) By Product: Vaccines, Drugs
2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications
3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses
Subsegments:
1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines
2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs
What Regions Are Influencing the Dynamics of the mRNA Therapeutics Market?
North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Scope and Reach of the mRNA Therapeutics Market Defined?
Messenger RNA (mRNA) therapeutics refers to a type of medical treatment that utilizes messenger RNA (mRNA) molecules to produce therapeutic proteins within the body. These therapeutics are used to prevent, treat, or cure diseases by directing cells to produce specific proteins that are needed for therapeutic effects.
Browse Through More Similar Reports By The Business Research Company:
Bipolar Disorder Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report
Cystic Fibrosis (CF) Therapeutics Global Market Report 2024
Peptide Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
